Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance, Inc.    WBA

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Trump to meet COVID-19 vaccine makers, distributors next week - Stat News

12/01/2020 | 01:01pm EST

Dec 1 (Reuters) - The Trump administration has invited vaccine manufacturers, drug distributors and government officials to a COVID-19 Vaccine Summit next week at the White House, Stat News reported on Tuesday, citing an invitation obtained by the news organization.

It is scheduled for Dec. 8 and will be attended by President Donald Trump, Vice President Mike Pence and private-sector executives, the report said https://www.statnews.com/2020/12/01/white-house-to-host-covid-19-vaccine-summit-as-trump-seeks-to-burnish-record.

The meeting would take place days ahead of reviews of vaccine candidates from Moderna Inc and Pfizer-BioNTech SE Inc by two separate panels of outside experts to the U.S. Food and Drug Administration (FDA).

Industry officials familiar with the plans for the summit interpreted it as an opportunity for the White House to pressure the FDA to quickly issue emergency use authorizations for the two vaccines candidates, the Stat report said.

Invitees include Pfizer, Moderna and drug distributors, pharmacies, and logistics companies including McKesson, Walgreens, CVS Health, United Parcel Service , and FedEx, the report said, citing three health industry people familiar with the event.

The companies did not immediately respond to Reuters request for comment. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 1.61% 76.26 Delayed Quote.11.65%
FEDEX CORPORATION -1.45% 252.56 Delayed Quote.-2.72%
MODERNA, INC. -0.05% 129.65 Delayed Quote.24.10%
PFIZER INC. -0.14% 36.7 Delayed Quote.-0.30%
WALGREENS BOOTS ALLIANCE, INC. -0.81% 48.92 Delayed Quote.23.67%
All news about WALGREENS BOOTS ALLIANCE, INC.
01/16WALGREENS : Statement in Support of President-Elect Biden's COVID-19 Update
BU
01/15WALGREENS BOOTS ALLIANCE : Some U.S. nursing home residents face delays for COVI..
RE
01/14ONE FAMILY PROPERTY : Announces Acquisition Of Investment Property
PR
01/13SECTOR UPDATE : Consumer Stocks Ending On Higher Ground Wednesday
MT
01/13SECTOR UPDATE : Consumer Stocks Scratching Out Narrow Gains
MT
01/13Walgreens to Launch Credit, Prepaid Debit Cards With Synchrony Financial, Mas..
MT
01/13SECTOR UPDATE : Consumer Stocks Inch Lower Before Wednesday's Market Open
MT
01/13Walgreens to Launch Credit, Debit Cards
DJ
01/13WALGREENS BOOTS ALLIANCE : Buys Major Stake in Automation Solutions Provider iA ..
MT
01/12Facebook, GM among brands to help fund Ad Council vaccine campaign
RE
More news
Financials (USD)
Sales 2021 145 B - -
Net income 2021 2 578 M - -
Net Debt 2021 11 868 M - -
P/E ratio 2021 15,3x
Yield 2021 3,90%
Capitalization 42 269 M 42 269 M -
EV / Sales 2021 0,37x
EV / Sales 2022 0,35x
Nbr of Employees 277 000
Free-Float 61,0%
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 46,37 $
Last Close Price 48,92 $
Spread / Highest target 30,8%
Spread / Average Target -5,22%
Spread / Lowest Target -24,4%
EPS Revisions
Managers and Directors
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
James Kehoe Global Chief Financial Officer & Executive VP
Sector and Competitors